PharmaShots | Incisive News in 3 Shots

Subscribe Now

Pharnext

Pharnext Reports the Completion of Patient Enrollment in the P-III (PREMIER) Trial of PXT3003 for the Treatment of Charcot-Marie-Tooth Disease Type 1A

Pharnext Reports the Completion of Patient Enrollment in the P-III (PREMIER) Trial of PXT3003 for the Treatment of Charcot-Marie-T...

May 31, 2022

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us